Lupin, INC.

Manufacturer of generic pharmaceuticals, biosimilars, and branded pharmaceuticals.

Based in MD

🤖

AI Overview

With $750K in lobbying spend across 16 quarterly filings, Lupin, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2025.

$750K
Total Spend
5
Years Active
1
Firms Hired
4
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$100K
2022$200K
2023$200K
2024$200K
2025$50K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Lupin, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEWhite House Office
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Defense

Advocacy for U.S. production of key pharmaceuticals necessary to support the U.S. supply chain related to pandemic preparedness and prevention

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.